Shyam Patel

Stem Cell Agency Expands Industry Alliance Program to  Accelerate Therapies

/ Kevin McCormack / Leave a comment

An ever-growing array of academic and industry resources are required to rapidly translate scientific discoveries and emerging technologies toward safe and effective regenerative medicine therapies for patients. To help, the California Institute for Regenerative Medicine (CIRM) is creating a network of Industry Resource Partners (IRP) that will make its unique resources available to help accelerate … Continue reading Stem Cell Agency Expands Industry Alliance Program to  Accelerate Therapies

Graphite Bio launches and will prepare for clinical trial based on CIRM-funded research

/ Yimy Villa / Leave a comment

Josh Lehrer, M.D., CEO of Graphite Bio This week saw the launch of the 45th startup company enabled by CIRM funding of translational research at California academic institutions. Graphite Bio officially launched with the help of $45M in funding led by bay area venture firms Versant Ventures and Samsara BioCapital to spinout a novel CRISPR … Continue reading Graphite Bio launches and will prepare for clinical trial based on CIRM-funded research

Meet Team CIRM: the People Behind the Mission to Save Lives

/ Todd Dubnicoff / Leave a comment

During our Month of CIRM blog series, we've been featuring the researchers, clinicians, patients, patient advocates, institutions and companies that are striving to accelerate stem cell treatments to patients with unmet medical needs. But there's one group that we haven't discussed yet: the dedicated members of the CIRM team.  They don't get a lot of … Continue reading Meet Team CIRM: the People Behind the Mission to Save Lives